Immunogenicity

Author Title Reference Y V
Bano, N Binding of Autoantibodies Varies Widely between β1-Adrenergic Receptor (β1-AR) Constructs AAPS 2014 Poster
Piper, E et al A phase II placebo-controlled study of tralokinumab in moderate-to-severe asthma Eur Respir J. 2013 February; 41(2): 330–338 2013 PMID
Eckersten, A et al Development of an automated ADA immunoassay with integrated acid dissociation and neutralization 2011 PDF
Colombo, L et al New analytical technologies: Pharmaceutical applications to proteins and antibodies. An industry perspective National meeting on medicinal chemistry (NMMC), Abano Terme, Italy, Book of abstracts, p39-40, October 2010 2010
Mora, J et al Application of the Gyrolab™ platform to ligand-binding assays: a user’s perspective Bioanalysis 2010, 2 (10) 1711–1715 2010 PMID
Poelmans, S et al Immunogenicity monitoring during preclinical development of Nanobodies®: comparing assay formats and species matrices AAPS 2010 PDF
Somerfield, J et al A novel strategy to reduce the immunogenicity of biological therapies J Immunology 2010, 185 (1) 763-768 2010 PMID
Brady, K Utility of the Gyros Gyrolab in Research and DMPK - an automated ligand binding assay platform 2010 PDF

You can view further information on selected references through the link in the column ‘View’ on the far right.

PMID: PubMed ID
PDF: Download the document as a PDF file